TrialBlood cancer journal2024

Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.

Gianluca Cavallaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.